我要投票 维存在叶酸行业中的票数:481
· 外 推 电 报 ·
2025-11-22 17:47:07 星期六

【维存是哪个国家的品牌?】

维存是什么牌子?「维存」是杏辉天力(杭州)药业有限公司旗下著名品牌。该品牌发源于台湾,由创始人王昭日在1995-06-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力维存品牌出海!将品牌入驻外推网,定制维存品牌推广信息,可以显著提高维存产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

杏辉天力(杭州)药业有限公司隶属于台湾上市公司杏辉医药集团,是杏辉集团较大的境外投资。2001年在杏辉董事会,“ 布局全球, 跨足国际, 发展全球策略及远景 “ 之指导方针下,杏辉天力药业创建于浙江省杭州市余杭区。初期厂址位于杭州市老余杭,后配合政府规划,搬迁至杭州市临平城区余杭经济开发区现址。

杏辉天力药业目前主业在天然植物提取物,植物营养素,有机种植规划、农场管理及中草药。乃一以研发为导向之创新型公司。拥有多项国内外产品专利,员工约170人。生产设备为一现代化药品级GMP,及ISO认证之自动化专业工厂。 厂房距临平中心约2公里,东邻新颜港,西邻红丰路,南靠北沙路,交通便利,水、电、汽、排污等配套设施齐全,占地面积为79亩。因应业务不断成长,公司于2017年完成新现代化植提多功能厂房三座,将成为大中华区生技业界具市场竞争力之生产基地。

杏辉天力旗下并拥有一个位于新疆于田县之大型有机种植基地及其所属公司,和田天力沙生药物开发有限责任公司,专司药材供给及种植。核心工作团队整合种植、 研发、 临床、法规、 制造、专利、商务、及相关供应炼等。

杏辉天力药业其它的生产经营范围尚有:生产西药、中成药、原料药;并开发和生产保健品。剂型含盖药品液体、胶囊、胶衣锭、颗粒、粉剂等多项。公司设有严格的品管制度,并按照G.M.P.的要求生产并提供给消费者放心之产品。 杏辉天力药业为杭州市余杭区重点骨干企业。公司将本着一贯〝诚信、务实、创新〞的企业精神,为客户及终端消费者提供良好的服务及高质量的产品.

专业及服务

杏辉天力药业团队实力坚强,拥有各类植化、植提、药学、医学、中西药品、保健食品、食品、营养、国贸、市场营销等人才。博、硕士及大学本科以上专业人员占公司所有人力约50%以上。提供之专业服务以满足客户需求为导向,有效结合种植、研发、临床、法规、制造、专利、及相关供应炼成本会计及业务等面向,有效整合及执行工作。


英文翻译:Xinghui Tianli (Hangzhou) Pharmaceutical Co., Ltd. belongs to Xinghui Pharmaceutical Group, a listed company in Taiwan, which is a large overseas investment of Xinghui group. In 2001, Xinghui Tianli Pharmaceutical Co., Ltd. was founded in Yuhang District, Hangzhou City, Zhejiang Province, under the guidance of the board of directors of Xinghui, "global layout, cross international development, global strategy and vision". The initial site is located in old Yuhang, Hangzhou, and then moved to the current site of Yuhang Economic Development Zone, Linping City, Hangzhou, in cooperation with the government planning. At present, Xinghui Tianli pharmaceutical is mainly engaged in natural plant extracts, plant nutrients, organic planting planning, farm management and Chinese herbal medicine. Is a R & D-oriented innovation company. With a number of domestic and foreign product patents, about 170 employees. The production equipment is a modern GMP and ISO certified automation factory. The plant is about 2km away from Linping center, adjacent to xinyangang in the East, Hongfeng road in the west, Beisha road in the south, with convenient transportation, complete water, electricity, gas, sewage and other supporting facilities, covering an area of 79mu. In response to the continuous growth of business, the company completed three new modern multi-functional plants in 2017, which will become a production base with market competitiveness in the biotechnology industry in Greater China. Xinghui Tianli owns a large-scale organic planting base and its affiliated company located in Yutian County, Xinjiang, and Hotan Tianli ShaSheng Pharmaceutical Development Co., Ltd., which specializes in the supply and planting of medicinal materials. The core team integrates planting, R & D, clinical, regulatory, manufacturing, patent, business, and related supply chain. Other production and business scope of Xinghui Tianli Pharmaceutical Co., Ltd. include: production of Western medicine, Chinese patent medicine and API; and development and production of health products. The dosage form includes liquid, capsule, gel coated ingot, granule, powder, etc. The company has strict quality control system, and according to the requirements of g.m.p. to produce and provide consumers with products at ease. Xinghui Tianli pharmaceutical is a key backbone enterprise in Yuhang District, Hangzhou. The company will, in line with the enterprise spirit of "integrity, pragmatism and innovation", provide customers and end consumers with good services and high-quality products. The professional and service team of Xinghui Tianli pharmaceutical industry is strong, with all kinds of talents in planting, planting, medicine, medicine, Chinese and Western medicine, health food, food, nutrition, international trade, marketing, etc. More than 50% of the company's personnel are professionals with bachelor's degree, master's degree and above. The professional services provided are oriented to meet the needs of customers, and effectively integrate and implement the work in combination with planting, R & D, clinical, regulatory, manufacturing, patent, and related supply refining cost accounting and business.

本文链接: https://www.waitui.com/brand/019c01f13.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

报告:“成分党”成为美妆主流消费群体

毕马威近日发布的《"颜"值经济新篇章:2025年中国美妆市场行业报告》(以下简称《报告》)显示,据调查,58.8%的消费者将产品成分作为购买决策的首要考量因素,“成分党”成为主流消费群体。与此同时,300-500元中端价格带产品市场份额显著提升,而超低价与高端市场则双双承压,反映出消费者在追求"悦己"体验的同时,更加注重产品的实际功效与性价比。(新浪财经)

2小时前

美联储传声筒:鲍威尔不是降息的最大障碍 美联储内部共识机制濒临瓦解

“美联储传声筒”Nick Timiraos撰文称,特朗普本周表示,他预计在明年5月任命新的美联储主席后,利率将大幅下降。然而,美联储内部反对12月降息声浪越来越大,这意味着他的愿望可能难以实现。无论鲍威尔在12月选择按兵不动还是降息,他都面临近八年任期内最严重的内部阻力。这种分歧可能延续至明年,这意味着,即便更换主席,也并不等于就能确保会有更多降息。一些人担忧,若特朗普无法如愿以偿,可能会采取更激进手段削弱央行独立性,以换取降息。(金十数据APP)

2小时前

第八届进博会,上海合作交流采购团达成意向采购额7.12亿元

11月21日下午,第八届中国国际进口博览会上海市合作交流采购团总结展示交流活动在闵行区虹桥品汇成功举办。据介绍,本届进博会上海市合作交流采购团采购成交再创新高,共达成意向采购额7.12亿元人民币,比上届提升4.71%,累计意向采购额突破30亿元。采购团规模也进一步扩大,分团总数增至33家,共组织30批次、近760人次走进进博会参观交流,参与企业数量创历年新高。(界面新闻)

2小时前

《哪吒2》不参加奥斯卡竞逐

当地时间11月21日,奥斯卡奖的主办方美国电影艺术与科学学院公布了符合资格参与最佳纪录长片、最佳国际影片以及最佳动画长片三个奖项竞逐的影片大名单。在最佳动画长片领域,今年有35部影片有资格“冲奥”,意外的是,《哪吒之魔童闹海》并不在其中。另一方面,《罗小黑战记2》榜上有名。(澎湃新闻)

2小时前

IDEA研究院孵化企业视启未来获近亿元融资

36氪获悉,孵化自IDEA研究院的视觉大模型企业,视启未来(深圳)科技有限公司宣布完成近亿元天使轮融资。本轮由A股上市公司安凯微领投,昊辰资本、德虎资本、元禾璞华、银杏谷资本、力合中科、数字未来、九安智能等机构跟投。

2小时前

本页详细列出关于维存的品牌信息,含品牌所属公司介绍,维存所处行业的品牌地位及优势。
咨询